Advertisement
Lipophilic statin use is associated with significantly reduced hepatocellular carcinoma incidence and mortality in adults with chronic viral hepatitis

Lipophilic Statins May Cut Liver Cancer in Chronic Viral Hepatitis

0
Inverse link is dose-dependent; lowest 10-year HCC risk seen with 600 or more lipophilic statin cDDDs
Despite a recent dental visit

Minority, Low-Income Individuals Less Likely to Receive Oral Cancer Screening

0
Education level, insurance type also may affect likelihood of oral cancer screening at dental visit
Among patients with hepatitis C virus infection and complete response to hepatocellular carcinoma treatment

DAAs Cut Deaths in Those Treated for HCV-Related Liver Cancer

0
Findings seen for patients receiving direct-acting antivirals with complete response to liver cancer treatment
The U.S. Preventive Services Task Force recommends that women who are at increased risk for BRCA1/2 mutations should undergo genetic counseling

USPSTF Recommends Genetic Counseling for High BRCA Risk

0
But counseling not recommended for women without personal, family history, ancestry associated with BRCA mutations
For patients with multiple myeloma receiving immunomodulatory drugs

SAVED Score Can Predict Risk for VTE in Multiple Myeloma

0
Score outperforms current NCCN guidelines for MM patients receiving immunomodulatory therapy
An artificial intelligence program outperforms pathologists for differentiating ductal carcinoma in situ from atypia

AI Program May Aid in Pathologic Evaluation of Breast Biopsies

0
Computer-based automated approach promising for differentiating ductal carcinoma in situ from atypia
The economic burden of disease progression is considerable among multiple myeloma patients receiving drug therapy across all lines of therapy

Cost Burden of Disease Progression High in Multiple Myeloma

0
For patients receiving drug therapy, economic burden substantial across lines of therapy
From 2000 to 2016

Burden of Obesity-Associated Cancers Shifted to Younger Age Groups

0
Large study shows particular increase in the 50- to 64-year-old age group from 2000 to 2016
A vaping industry group has launched legal action to delay the U.S. Food and Drug Administration's upcoming review of electronic cigarettes.

Vaping Industry Group Sues to Delay FDA Review of E-Cigarettes

0
Current deadline is May 2020 for all companies to submit their vaping products for federal review
Smokers would have to get past some gruesome imagery to purchase a pack of cigarettes under a new rule proposed Thursday by the U.S. Food and Drug Administration.

FDA Proposes Graphic Warning Labels on Cigarettes

0
New labels would be the most significant change to cigarette labels in more than 35 years